c-Met is an important transmembrane receptor for regulating cancer cell migration and invasion (Arnold et al. 2017) and is closely correlated with poorer prognosis in various cancer types (Liu et al. 2012; Park et al. 2012), including OTSCC (Lim et al. 2012; Lo Muzio et al. 2004). The gene discussed is MET; the disease is cancer.